Molecule Holdings Stock Performance
| EVRRF Stock | USD 0 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Molecule Holdings are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Molecule Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Molecule Holdings is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 902.5 K | |
| Total Cashflows From Investing Activities | 167 K | |
| Free Cash Flow | -2.9 M |
Molecule |
Molecule Holdings Relative Risk vs. Return Landscape
If you would invest 0.25 in Molecule Holdings on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Molecule Holdings or generate 0.0% return on investment over 90 days. Molecule Holdings is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Molecule, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Molecule Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Molecule Holdings' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Molecule Holdings, and traders can use it to determine the average amount a Molecule Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EVRRF |
Based on monthly moving average Molecule Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Molecule Holdings by adding Molecule Holdings to a well-diversified portfolio.
Molecule Holdings Fundamentals Growth
Molecule Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Molecule Holdings, and Molecule Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Molecule Pink Sheet performance.
| Return On Equity | -10.88 | |||
| Return On Asset | -0.41 | |||
| Profit Margin | (2.43) % | |||
| Operating Margin | (2.15) % | |||
| Current Valuation | 5.39 M | |||
| Shares Outstanding | 97.78 M | |||
| Price To Earning | (2.27) X | |||
| Price To Book | 12.35 X | |||
| Price To Sales | 0.0001 X | |||
| Revenue | 455.26 K | |||
| EBITDA | (3 M) | |||
| Cash And Equivalents | 73.25 K | |||
| Total Debt | 817.09 K | |||
| Debt To Equity | 1.37 % | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (2.87 M) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 5.96 M | |||
| Retained Earnings | (26.52 M) | |||
| Current Asset | 1.13 M | |||
| Current Liabilities | 622 K | |||
About Molecule Holdings Performance
By analyzing Molecule Holdings' fundamental ratios, stakeholders can gain valuable insights into Molecule Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Molecule Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Molecule Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. Molecule Holdings is traded on OTC Exchange in the United States.Things to note about Molecule Holdings performance evaluation
Checking the ongoing alerts about Molecule Holdings for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Molecule Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Molecule Holdings generated a negative expected return over the last 90 days | |
| Molecule Holdings has some characteristics of a very speculative penny stock | |
| Molecule Holdings has a very high chance of going through financial distress in the upcoming years | |
| Molecule Holdings has accumulated 817.09 K in total debt with debt to equity ratio (D/E) of 1.37, which is about average as compared to similar companies. Molecule Holdings has a current ratio of 0.3, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Molecule Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Molecule Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Molecule Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Molecule to invest in growth at high rates of return. When we think about Molecule Holdings' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 455.26 K. Net Loss for the year was (4.23 M) with loss before overhead, payroll, taxes, and interest of (499.74 K). | |
| Molecule Holdings has accumulated about 73.25 K in cash with (2.87 M) of positive cash flow from operations. | |
| Roughly 17.0% of Molecule Holdings shares are held by company insiders |
- Analyzing Molecule Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Molecule Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Molecule Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Molecule Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Molecule Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Molecule Holdings' pink sheet. These opinions can provide insight into Molecule Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Molecule Pink Sheet analysis
When running Molecule Holdings' price analysis, check to measure Molecule Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecule Holdings is operating at the current time. Most of Molecule Holdings' value examination focuses on studying past and present price action to predict the probability of Molecule Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecule Holdings' price. Additionally, you may evaluate how the addition of Molecule Holdings to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |